Evidence map›Paper›PMID 28963209›Full record

ArticleGenome announcements2017

Draft Genome Sequences of the Avirulent

Paul A Beare, Brendan M Jeffrey, Craig A Martens, Robert A Heinzen

Abstract read
In one paragraph

Article in Genome announcements, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Identification of essential genes inMicrobial genomics · 2023
    Article
  3. TheJournal of bacteriology · 2021
    Article
  4. TheFrontiers in cellular and infection microbiology · 2020
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paul A BeareCoxiella Pathogenesis Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana, USA.
Brendan M JeffreyBioinformatics and Computational Biosciences Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Craig A MartensGenomics Unit, Research Technologies Section, Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana, USA.
Robert A HeinzenCoxiella Pathogenesis Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana, USA rheinzen@niaid.nih.gov.

Funding

Infectious Diseases Research Technologies Core - RMLZICAI001052 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHERRY, JAMES · 2009 to 2025
$133.3M
Cellular and Developmental Biology of Coxiella burnetiiZ01AI000931 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI HEINZEN, ROBERT A · 2003 to 2008
$2.2M
Genetics of Coxiella burnetiiZ01AI000946 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI HEINZEN, ROBERT A · 2004 to 2008
$1.4M
Intramural NIH HHS Z01 AI000931Intramural NIH HHS Z01 AI000946
6 · The paper itself

Abstract

Here, we present the draft genome sequences of the

Identifiers

PMID28963209
PMCPMC5624755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.